Strid Group’s AbbVie ABBV Stock Holding History

Strid Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77M	Hold	11,022	–	–	0.31%	24
2026 Q1	$2.4M	Sell	11,022 -20	-0.2%	-$4.44K	0.3%	23
2025 Q4	$2.52M	Buy	11,042 +20	+0.2%	+$4.56K	0.31%	23
2025 Q3	$2.55M	Buy	11,022 +2	+0%	+$407	0.32%	23
2025 Q2	$2.05M	Buy	+11,020	New	+$2.05M	0.29%	22

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Strid Group's ABBV Position: Q2 2026 in Review

Strid Group held its AbbVie (ABBV) position steady in Q2 2026 at 11,022 shares worth $2.77M. The position accounts for 0.31% of the portfolio, ranked #24.

Strid Group first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Strid Group held 11,022 shares of AbbVie worth $2.77M as of Q2 2026.
Strid Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.31% of Strid Group's portfolio in Q2 2026, its #24 holding.
Strid Group first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strid Group's 13F filing for Q2 2026, filed 23 Jul 2026.